<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Systemic therapy for metastatic endometrial cancer</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Systemic therapy for metastatic endometrial cancer</h1>
<div class="graphic"><div class="figure"><div class="ttl">Systemic therapy for metastatic endometrial cancer</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd"><p>This algorithm represents a suggested approach. However, other approaches are also reasonable. For example, for select patients, endocrine therapy is an alternative to first-line therapy chemotherapy, or it may be used as a later-line option for those who have progressed on chemotherapy- or immunotherapy-based options. Endocrine therapy is well tolerated and lacks the usual toxicities associated with cytotoxic chemotherapy. Approximately 15 to 30% of women respond to endocrine therapy.</p>
Factors that may predict response to endocrine therapy include the following:
<ul class="decimal_heading">
<li>Grade 1 or 2 endometrioid endometrial cancer.</li>
<li>Asymptomatic or minimally symptomatic disease.</li>
<li>Hormone receptor-positive cancer (mixed data; some studies suggest increased response rates with endocrine treatment).</li>
</ul></div><div class="graphic_footnotes"><p>HER2: human epidermal growth factor receptor 2; MMR: mismatch repair; TMB: tumor mutational burden; pMMR: mismatch repair proficient; dMMR: mismatch repair deficient.</p>
<p>* Some experts may reasonably add pembrolizumab or dostarlimab for pMMR tumors; we await incorporation into guidelines or regulatory approval for use in this subset, however.</p>
<p>¶ For patients who have relapsed with a treatment-free interval following carboplatin and paclitaxel of ≥6 months, we typically suggest retreatment with chemotherapy. Endocrine therapy represents an acceptable alternative for select patients. Although we have chosen an interval of 6 months as a cutoff, extrapolating from the definition of platinum sensitivity in ovarian cancer, high-quality data regarding platinum sensitivity are lacking in endometrial cancer. In reality, sensitivity is expected to be a continuum, and 6 months should not be considered an absolute condition for treatment decisions; other factors including patient preferences and tolerance of prior treatments should also be weighed.</p>
<p>Δ Refer to UpToDate topics on subsequent line systemic therapy for metastatic endometrial cancer.</p>
◊ In the absence of direct comparisons, a choice between pembrolizumab and dostarlimab for such tumors should be based on factors such as availability and cost.</div><div id="graphicVersion">Graphic 130057 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
